Matrix metalloproteinase levels in early HIV infection and relation to in vivo brain status.
about
HIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentChronic low-level expression of HIV-1 Tat promotes a neurodegenerative phenotype with aging.Cognitive Impairment and Persistent CNS Injury in Treated HIV.Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.The role of MMP genes in recurrent depressive disorders and cognitive functions.The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity.
P2860
Matrix metalloproteinase levels in early HIV infection and relation to in vivo brain status.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Matrix metalloproteinase level ...... ation to in vivo brain status.
@en
Matrix metalloproteinase level ...... ation to in vivo brain status.
@nl
type
label
Matrix metalloproteinase level ...... ation to in vivo brain status.
@en
Matrix metalloproteinase level ...... ation to in vivo brain status.
@nl
prefLabel
Matrix metalloproteinase level ...... ation to in vivo brain status.
@en
Matrix metalloproteinase level ...... ation to in vivo brain status.
@nl
P2093
P2860
P1476
Matrix metalloproteinase level ...... ation to in vivo brain status.
@en
P2093
Ann B Ragin
Christina L Sammet
Cindy Zadikoff
Hongyan Du
Leon G Epstein
Riti Mahadevia
P2860
P2888
P304
P356
10.1007/S13365-013-0197-3
P577
2013-08-27T00:00:00Z